Ann: PTX unveils new clinic-ready CAR-T enhancement platform, page-101

Going to guess that all the traders are set up at 16-17 cents for the news driven pump and dump next Wed/Thur.
No one left willing to sell at 17 for fomo. Last stop hunt didn't find much.

I end to agree that the overly optimistic (non-public evidence?) based language is starting to give a bit marketing fatigue. Would be nice to get something with a bit more meat on it. I'm sure it's coming and there are commercial reasons to hold back, but apart from some vague pointy arrows on a slide, it's difficult for us lay shareholders to understand the extent of progress without material evidence. That said, I'm still not going anywhere just yet.

Lets all just hope the A in cellpryme A doesn't stand for anticlimax.